Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
Genome Biology
|
October 15, 2008
Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas
Frank Westermann, Daniel Muth, Axel Benner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 27, 2007
High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN status
Frank Westermann, Kai-Oliver Henrich, Jun S Wei, et al.
Oncogene
|
April 18, 2002
The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2
Marc B Godfried, Monique Veenstra, Peter v Sluis, et al.
BMC Genomics
|
September 24, 2004
cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma
Qing-Rong Chen, Sven Bilke, Jun S Wei, et al.
International Journal of Cancer
|
October 27, 2006
Nonrandom distribution of oncogene amplifications in bilateral breast carcinomas: Possible role of host factors and survival bias
Evgeny N Suspitsin, Anna P Sokolenko, Alexandr V Togo, et al.
Cancer Research
|
October 7, 2004
Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma
Jun S Wei, Braden T Greer, Frank Westermann, et al.
The Journal of Biological Chemistry
|
March 18, 2010
Direct and coordinate regulation of ATP-binding cassette transporter genes by Myc factors generates specific transcription signatures that significantly affect the chemoresistance phenotype of cancer cells
Antonio Porro, Michelle Haber, Daniel Diolaiti, et al.
Journal of the National Cancer Institute
|
July 30, 2011
ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux
Michelle J Henderson, Michelle Haber, Antonio Porro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 23, 2010
Prognostic impact of gene expression-based classification for neuroblastoma
André Oberthuer, Barbara Hero, Frank Berthold, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2014
Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers
André Oberthuer, Dilafruz Juraeva, Barbara Hero, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
Genome Biology
|
October 15, 2008
Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas
Frank Westermann, Daniel Muth, Axel Benner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 27, 2007
High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN status
Frank Westermann, Kai-Oliver Henrich, Jun S Wei, et al.
Oncogene
|
April 18, 2002
The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2
Marc B Godfried, Monique Veenstra, Peter v Sluis, et al.
BMC Genomics
|
September 24, 2004
cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma
Qing-Rong Chen, Sven Bilke, Jun S Wei, et al.
International Journal of Cancer
|
October 27, 2006
Nonrandom distribution of oncogene amplifications in bilateral breast carcinomas: Possible role of host factors and survival bias
Evgeny N Suspitsin, Anna P Sokolenko, Alexandr V Togo, et al.
Cancer Research
|
October 7, 2004
Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma
Jun S Wei, Braden T Greer, Frank Westermann, et al.
The Journal of Biological Chemistry
|
March 18, 2010
Direct and coordinate regulation of ATP-binding cassette transporter genes by Myc factors generates specific transcription signatures that significantly affect the chemoresistance phenotype of cancer cells
Antonio Porro, Michelle Haber, Daniel Diolaiti, et al.
Journal of the National Cancer Institute
|
July 30, 2011
ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux
Michelle J Henderson, Michelle Haber, Antonio Porro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 23, 2010
Prognostic impact of gene expression-based classification for neuroblastoma
André Oberthuer, Barbara Hero, Frank Berthold, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2014
Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers
André Oberthuer, Dilafruz Juraeva, Barbara Hero, et al.
Page
of 7